Exhibit 31.1


CERTIFICATIONS





I, Jing’an Wang, certify
that:




1.I have reviewed this report on Form
10-Q for the quarter ended March 31, 2008 of Huifeng Bio-Pharmaceutical
Technology, Inc.;




2. Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a
material factnecessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this
report;




3. Based on my knowledge, the financial
statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented in this
report;




4. The registrant's other certifying
officers andI are
responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control
over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f) for theregistrant and
have:




(a) designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information relating to the
registrant, including its consolidatedsubsidiaries, is made known to us by
others within those entities, particularly during the period in which this
report is being prepared;




(b) designed such internal control over
financial reporting, or caused such internal control over financial
reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements, for external
purposes in accordance with generally accepted accounting
principles;




(c)evaluated the effectiveness of the
registrant's disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based onsuch evaluation; and




(d) disclosed in this report any change
in the registrant's internal control over financial reporting that occurred
during the registrant's most recent fiscal quarter (the registrant's fourth
fiscal quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially affect, the registrant's internal control
over financial reporting; and




5. The registrant's other certifying
officer and I have disclosed, based on our most recent evaluation of
internal control over
financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent
functions):




(a) all significant deficiencies and
material weaknesses in the designor operation of internal control over
financial reporting which are reasonably likely to adversely affect the
registrant's ability to record, process, summarize and report financial
information; and




(b) any fraud, whether or not material,
that involves management or
other employees who have a significant role in the registrant's internal control
over financial reporting.







Date:January20,
2009                                                                By:/s/
Jing’an
Wang


Jing’an Wang


Chief Executive
Officer